To discover novel drug targets and develop compounds for the treatment of unmet needs within central nervous system disorders.

Welcome to Angita Pharmaceuticals

Angita Pharmaceuticals is dedicated to the discovery of novel targets and drug candidates for the treatment of unmet needs in diseases of the Central Nervous System (CNS) and indications in which the CNS plays an important function. We have a number of projects ongoing and are constantly seeking to increase the diversity of our discovery portfolio through collaborative projects and in-licensing opportunities.

 

New Angita client area

We're pleased to announce we've recently set up a new client area for the storage and transfer of files and documents.  To get access, please click here to request a username and password.

Latest News & Events

    BIO-Europe Spring 2012

    17 Feb, 2012
    Meet Angita at BioEurope Spring, Mar 19-21 2012 Read more.


    BioTrinity Conference April 2012

    17 Feb, 2012
    Newbury, UK between the 24th-26th April 2012 Read more.


    Angita appear in Biotech News

    01 Mar, 2011
    Read more.


    Angita appear in Biotech News

    07 Oct, 2010
    Read more.


Affiliates & Sponsors

Contact Details

Angita B.V.
P.O. Box 2253, 9704 CE Groningen, The Netherlands

Tel: +44 7917 725755
Fax: +31 50 5757399
Email: info@angitapharma.com